MedMarket Diligence has completed its comprehensive 2012 assessment of this global market to reveal the size, outlook and opportunities for current and hopeful competitors in each technology and geographic area. This report details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, including tapes, sutures/staples/mechanical closure, hemostats, fibrin sealants/glues and high-strength medical adhesives and anti-adhesion products.
The report details current clinical and technology developments, with data on products in development (detailing market status) and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. The report provides full year historical actual data for 2010 and 2011 and forecast 2012-2017 of the markets for these technologies, with emphasis on the market impact of new technologies through the forecast period. The report provides specific forecasts and shares of the worldwide market by segment for Americas (detail for U.S., Rest of North America and Latin America), Europe (detail for United Kingdom, Germany, France, Italy, Spain, Rest of Europe), Asia/Pacific (detail for Japan, Korea, Rest of Asia/Pacific) and Rest of World.
The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.
The report establish the current worldwide market size for major technology segments as a baseline for and projecting growth in the market through 2017. The report assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.
The report profiles 122 active companies in this industry, providing data on their current products, current market position and products under development.
Table of Contents
EXECUTIVE SUMMARY
SECTION 1: CLINICAL NEED, CASELOAD AND PROCEDURE VOLUME
1.1 Anatomy and Physiology of Tissue Repair
1.2 The Skin
1.3 Internal Tissues and Organ
1.4 Wound Classification and Types
1.4.1 Classification by Morphology and Severity
1.4.2 Classification by Cause
1.4.3 Surgical Wounds
1.5 Caseload
1.5.1 Cardiovascular
1.5.5.1 Coronary Heart Disease
1.5.1.2 Dysfunctional Heart Valves
1.5.1.3 Peripheral Vascular Disorders
1.5.1.4 Abnormal Aortic Aneurysms
1.5.1.5 Drivers of Caseloads for Cardiac Surgery
1.5.2 Neurological
1.5.2.1 Stroke
1.5.2.2 Parkinson’s Disease
1.5.2.3 Epilepsy
1.5.2.4 Traumatic Injury
1.5.2.5 Peripheral Nerve Treatment
1.5.2.6 Drivers of Neurological Surgery
1.5.3 Orthopedic
1.5.3.1 Hip Replacement
1.5.3.2 Knee Replacements
1.5.3.3 Cartilage Repair
1.5.3.4 Ligament Damage
1.5.3.5 Bone Grafting
1.5.3.6 Vertebral Disc Repair
1.5.3.7 Drivers of Orthopedic Surgery
1.5.4 Urological
1.5.4.1 Incontinence
1.5.4.2 Drivers of Urological Surgery
1.5.5 Dermatological
1.5.5.1 Burns
1.5.5.2 Pressure Ulcers
1.5.5.3 Diabetic Ulcers
1.5.5.4 Venous Ulcers
1.5.5.5 Plastic Surgery
1.5.5.6 Drivers of Dermatological Surgery
1.6 The Role of Modern Sealant, Securement and Hemostatic Products in Surgery
1.6.1 Fibrin Sealants
1.6.2 High-Strength Glues
SECTION 2: SCIENCE, TECHNOLOGY, DEVELOPMENT, CLINICAL AND REGULATORY CHALLENGES
2.1 Tissue Healing
2.1.1 Hemostasis
2.1.2 Proliferation and Maturation
2.1.3 Factors That Affect Healing
2.2 Product Development
2.3 Development Timelines
2.3.1 Collagen and Thrombin Combination
2.3.2 Polyethylene Glycol Polymer (PEG)
2.3.3 Albumin Cross-Linked with Glutaraldehyde
2.3.4 Delivery Systems
2.4 Cost-Effectiveness
2.5 Regulatory Challenges
2.5.1 Approval Processes
2.5.2 History of Product Development
2.5.3 Regulatory Aspects
SECTION 3: PRODUCTS, TECHNOLOGIES, AND FORECAST OPPORTUNITY
3.1 Overview
3.1.1 Development Timeline
3.2 Sutures, Staples and other Mechanical Closure Devices
3.2.1 Sutures, Staples and Mechanical Closure Competitors and Products
3.2.2 Sutures, Staples and Mechanical Closure Products in Development
3.2.3 Sutures, Staples and Mechanical Closure Market Analysis and Forecast
3.3 Tapes
3.3.1 Medical Tape Competitors and Products
3.3.2 Medical Tape Market Analysis and Forecast
3.4 Hemostats
3.4.1 Hemostat Competitors and Products
3.4.2 Hemostat Products in Development
3.4.3 Hemostat Market Analysis and Forecasts
3.5 Fibrin and Other Sealant Products
3.5.1 Fibrin and Other Sealant Competitors and Products
3.5.2 Fibrin and Other Sealant Products in Development
3.5.3 Fibrin and Other Sealant Market Analysis and Forecasts
3.6 High-Strength Medical Adhesives
3.6.1 High-Strength Medical Adhesive Competitors and Products
3.6.2 High-Strength Medical Adhesive Products in Development
3.6.3 High-Strength Medical Adhesive Market Analysis and Forecasts
3.7 Post-Surgical Adhesion Prevention
3.7.1 Post-Surgical Adhesion Prevention Competitors and Products
3.7.2 Post-Surgical Adhesion Prevention Products in Development
3.7.3 Post-Surgical Adhesion Prevention Market Analysis and Forecasts
3.8 Wound Closure and Securement Markets: Global and Regional Analysis
3.8.1 Americas
3.8.2 European Union
3.8.3 Asia-Pacific
3.8.4 Rest of World
3.9 Worldwide Markets By Country and Segment
3.9.1 Americas
3.9.1.1 United States
3.9.1.1.1 Sutures & Staples
3.9.1.1.2 Mechanical Closure
3.9.1.1.3 Tapes
3.9.1.1.4 Hemostats
3.9.1.1.5 Fibrin & Other Sealants
3.9.1.1.6 High-Strength Medical Adhesives
3.9.1.1.7 Post-Surgical Adhesion Prevention
3.9.1.2 Rest of North America
3.9.1.2.1 Sutures & Staples
3.9.1.2.2 Mechanical Closure
3.9.1.2.3 Tapes
3.9.1.2.4 Hemostats
3.9.1.2.5 Fibrin & Other Sealants
3.9.1.2.6 High-Strength Medical Adhesives
3.9.1.2.7 Post-Surgical Adhesion Prevention
3.9.1.3 Latin America
3.9.1.3.1 Sutures & Staples
3.9.1.3.2 Mechanical Closure
3.9.1.3.3 Tapes
3.9.1.3.4 Hemostats
3.9.1.3.5 Fibrin & Other Sealants
3.9.1.3.6 High-Strength Medical Adhesives
3.9.1.3.7 Post-Surgical Adhesion Prevention
3.9.2 European Union
3.9.2.1 United Kingdom
3.9.2.1.1 Sutures & Staples
3.9.2.1.2 Mechanical Closure
3.9.2.1.3 Tapes
3.9.2.1.4 Hemostats
3.9.2.1.5 Fibrin & Other Sealants
3.9.2.1.6 High-Strength Medical Adhesives
3.9.2.1.7 Post-Surgical Adhesion Prevention
3.9.2.2 Germany
3.9.2.2.1 Sutures & Staples
3.9.2.2.2 Mechanical Closure
3.9.2.2.3 Tapes
3.9.2.2.4 Hemostats
3.9.2.2.5 Fibrin & Other Sealants
3.9.2.2.6 High-Strength Medical Adhesives
3.9.2.2.7 Post-Surgical Adhesion Prevention
3.9.2.3 France
3.9.2.3.1 Sutures & Staples
3.9.2.3.2 Mechanical Closure
3.9.2.3.3 Tapes
3.9.2.3.4 Hemostats
3.9.2.3.5 Fibrin & Other Sealants
3.9.2.3.6 High-Strength Medical Adhesives
3.9.2.3.7 Post-Surgical Adhesion Prevention
3.9.2.4 Spain
3.9.2.4.1 Sutures & Staples
3.9.2.4.2 Mechanical Closure
3.9.2.4.3 Tapes
3.9.2.4.4 Hemostats
3.9.2.4.5 Fibrin & Other Sealants
3.9.2.4.6 High-Strength Medical Adhesives
3.9.2.4.7 Post-Surgical Adhesion Prevention
3.9.2.5 Italy
3.9.2.5.1 Sutures & Staples
3.9.2.5.2 Mechanical Closure
3.9.2.5.3 Tapes
3.9.2.5.4 Hemostats
3.9.2.5.5 Fibrin & Other Sealants
3.9.2.5.6 High-Strength Medical Adhesives
3.9.2.5.7 Post-Surgical Adhesion Prevention
3.9.2.6 Rest of Europe
3.9.2.6.1 Sutures & Staples
3.9.2.6.2 Mechanical Closure
3.9.2.6.3 Tapes
3.9.2.6.4 Hemostats
3.9.2.6.5 Fibrin & Other Sealants
3.9.2.6.6 High-Strength Medical Adhesives
3.9.2.6.7 Post-Surgical Adhesion Prevention
3.9.3 Asia-Pacific
3.9.3.1 Japan
3.9.3.1.1 Sutures & Staples
3.9.3.1.2 Mechanical Closure
3.9.3.1.3 Tapes
3.9.3.1.4 Hemostats
3.9.3.1.5 Fibrin & Other Sealants
3.9.3.1.6 High-Strength Medical Adhesives
3.9.3.1.7 Post-Surgical Adhesion Prevention
3.9.3.2 Korea
3.9.3.2.1 Sutures & Staples
3.9.3.2.2 Mechanical Closure
3.9.3.2.3 Tapes
3.9.3.2.4 Hemostats
3.9.3.2.5 Fibrin & Other Sealants
3.9.3.2.6 High-Strength Medical Adhesives
3.9.3.2.7 Post-Surgical Adhesion Prevention
3.9.3.3 Rest of Asia-Pacific
3.9.3.3.1 Sutures & Staples
3.9.3.3.2 Mechanical Closure
3.9.3.3.3 Tapes
3.9.3.3.4 Hemostats
3.9.3.3.5 Fibrin & Other Sealants
3.9.3.3.6 High-Strength Medical Adhesives
3.9.3.3.7 Post-Surgical Adhesion Prevention
3.9.4 Rest of World
3.9.4.1 Sutures & Staples
3.9.4.2 Mechanical Closure
3.9.4.3 Tapes
3.9.4.4 Hemostats
3.9.4.5 Fibrin & Other Sealants
3.9.4.6 High-Strength Medical Adhesives
3.9.4.7 Post-Surgical Adhesion Prevention
SECTION 4: COMPANY PROFILES
4.1 3M
4.2 Abbott Laboratories
4.3 AccessClosure, Inc.
4.4 Adhesives Research, Inc.
4.5 Adhezion Biomedical, LLC
4.6 Advanced Medical Solutions Group plc/Medlogic Global
4.41 CSMG Technologies, Inc. (Live Tissue Connect, Inc.)
4.42 CuraMedical BV
4.43 Derma Sciences, Inc.
4.44 DuPont Applied BioSciences
4.45 Dynamic Techno Medicals Pvt. Ltd.
4.46 Entegrion, Inc.
4.47 Equimedical B.V.
4.48 Ferndale Laboratories
4.49 FibroGen, Inc.
4.50 FzioMed Inc.
4.51 Gelita Medical BV
4.52 GEM srl
4.53 Genzyme Biosurgery Inc.
4.54 GluStitch, Inc.
4.55 Graceduty Company Limited
4.56 Hartmann Group/Hartmann USA
4.57 HemCon Medical Technologies, Inc.
4.58 Hemostasis, LLC
4.59 HyperBranch Medical Technology, Inc.
4.60 Hy-Tape International
4.61 Incisive Surgical, Inc.
4.62 Innovasa Corporation
4.63 Integra Lifesciences Corporation
4.64 Interventional Therapies, LLC
4.65 Johnson & Johnson (Ethicon, Inc., Ethicon Endo-Surgery, Inc., Ethicon Biosurgery)
4.66 Kaketsuken (Chemo-Sero-Therapeutic Research Institute)
4.67 Kensey Nash Corporation
4.68 Kimberly-Clark Health Care
4.69 Kinetic Concepts, Inc.
4.70 Kookbo Chemicals Co., Ltd. (KB Chem.)
4.71 Kuros Biosurgery AG
4.72 Laboratoires Urgo (Urgo Medical)
4.73 LifeBond Ltd.
4.74 LifeScience PLUS
4.75 Lohmann & Rauscher
4.76 Marine Polymer Technologies, Inc.
4.77 Medafor, Inc.
4.78 Medisse
4.79 MedTrade Products, Ltd.
4.80 Meyer-Haake GmbH Medical Innovations
4.81 Mölnlycke Health Care AB
4.82 Morris Innovative
4.83 Motex Healthcare Corp.
4.84 NeatStitch Ltd.
4.85 Neomend, Inc.
4.86 Nobles Medical Technology
4.87 Nycomed (Takeda)
4.88 Ocular Therapeutix, Inc.
4.89 Omrix Biopharmaceuticals Inc. (Johnson & Johnson)
4.90 Opocrin S.p.A
4.91 Orthocon, Inc.
4.92 Orthovita, Inc. (Stryker)
4.93 Pathfinder Cell Therapy, Inc. (formerly SyntheMed)
4.94 Pfizer Inc.
4.95 Plasma Technologies, Inc.
4.96 Pluromed, Inc.
4.97 Polyganics BV
4.98 PolyHeal Ltd.
4.99 ProFibrix BV
4.100 Ranfac Corporation
4.101 Resorba Wundversorgung GmbH & Co. KG
4.102 Salient Surgical Technologies, Inc. (Medtronic)
4.103 Scion Cardio-Vascular, Inc.
4.104 Sea Run Holdings
4.105 Smith & Nephew plc
4.106 St. Jude Medical
4.107 Starch Medical, Inc.
4.108 STB Lifesaving Technologies, Inc.
4.109 Synovis Life Technologies
4.110 Teleflex Medical
4.111 Tenaxis Medical
4.112 ThermoGenesis Corporation
4.113 Thrombotargets Corp.
4.114 TissueSeal, LLC
4.115 Tissuemed Ltd.
4.116 Vascular Solutions, Inc.
4.117 Vivostat A/S
4.118 Wortham Laboratories, Inc.
4.119 Wound Care Technologies, Inc.
4.120 Z-Medica Corporation
4.121 Zimmer, Inc.
4.122 ZymoGenetics, Inc. (Bristol-Myers Squibb)
APPENDIX: COMPANY DIRECTORY
ADDENDUM: Dural Sealants in Cranial versus Spinal Applications, Worldwide Sales, 2010-2017
List of Exhibits
Exhibit ES-1: Estimated Prevalence of Various Wound Types, 2011
Exhibit ES-2: Factors That Affect Wound Healing
Exhibit ES-3: Global Market for Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention, 2010-2017 ($Millions)
Exhibit ES-4: Global Market Shares, Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, 2011
Exhibit 1-1: Skin Structure Illustrating Major Organelles and Skin Layers
Exhibit 1-2: Classification of Wounds by Morphology
Exhibit 1-3: Severity Classification of Wounds
Exhibit 1-4: Wound Classification by Etiology
Exhibit 1-5: Surgical Wound Classification
Exhibit 1-6: Estimated Prevalence of Various Wound Types, 2011
Exhibit 1-7: The Coagulation Cascade
Exhibit 1-8: Criteria for Adjunctive Use of Hemostats, Sealants, Glues and Adhesion Prevention Products in Surgery
Exhibit 1-9: Surgical Procedures with Potential for the Use of Hemostats, Sealants, Glues and Adhesion Prevention Products, Worldwide (Millions), 2011
Exhibit 1-10: Descriptions of Surgical Procedures Categories Benefitting from Closure and Securement Products
Exhibit 1-11: Prevalence of Common Cardiovascular Diseases, 2011 (000)
Exhibit 1-12: Potential for Neurological Applications, Prevalence of Applicable Disorders (000s), 2011
Exhibit 1-13: Potential for Orthopedic Applications, Frequency of Major Surgical Interventions (000)
Exhibit 1-14: Potential for Urological Applications, Prevalence of Applicable Disorders (000), 2011
Exhibit 1-15: Potential for Dermal Repair, Prevalence of Applicable Disorders (000), 2011
Exhibit 1-16: Applications of Fibrin and Other Sealants
Exhibit 1-17: Surgical Procedures Using Fibrin and Other Sealant Products
Exhibit 1-18: Surgical Indications for High-Strength Glues
Exhibit 2-1: Factors That Affect Wound Healing
Exhibit 2-2: Timescales for Development of Closure and Sealant Products
Exhibit 2-3: Variables Associated With Clinical Evaluation of Closure and Securement and Related Products
Exhibit 3-1: Global Market Shares, Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, 2011
Exhibit 3-2: Select Competitors in the Sutures, Staples and Other Mechanical Closure Devices Market
Exhibit 3-3: Worldwide Market Forecast for Sutures, Staples and Mechanical Closure Devices, 2010–2017, ($Millions)
Exhibit 3-4: Leading Competitors, Sutures, Staples and Mechanical Closure Devices, 2011
Exhibit 3-5: Select Competitors in the Medical Tapes Market
Exhibit 3-6: Global Medical Tape Market, 2010-2017 ($Millions)
Exhibit 3-7: Market Shares of Leading Competitors, Medical Tape, 2011
Exhibit 3-8: Select Characteristics of the Ideal Hemostatic Dressing
Exhibit 3-9: Select Competitors in the Hemostats Market
Exhibit 3-10: Global Hemostats Market, 2010-2017 ($Millions)
Exhibit 3-11: Hemostat Market Shares, 2011
Exhibit 3-12: Select Competitors in the Fibrin and Other Sealants Market
Exhibit 3-13: Global Fibrin and Other Sealants Market, 2010-2017 ($Millions)
Exhibit 3-14: Market Shares in Fibrin and Other Sealants, 2011
Exhibit 3-15: Select Competitors in the High Strength Medical Adhesives Market
Exhibit 3-16: Global High-Strength Medical Adhesives Market, 2010-2017 ($Millions)
Exhibit 3-17: Market Share Leaders, High-Strength Medical Adhesives, 2011
Exhibit 3-18: Select Competitors in the Post-Surgical Adhesion Prevention Market
Exhibit 3-19: Global Post-Surgical Adhesion Prevention Market, 2010-2017 ($Millions)
Exhibit 3-20: Leading Competitors in the Post-Surgical Adhesion Prevention Market, 2011
Exhibit 3-21: Global Market for Sealants and Wound Closure Devices, 2010-2017 ($Millions)
Exhibit 3-22: Percent of Total Market by Modality, 2010
Exhibit 3-23: Percent of Total Market by Modality, 2017
Exhibit 3-24: Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, the Americas, 2010-2017 ($Millions)
Exhibit 3-25: Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, United States, 2010-2017 ($Millions)
Exhibit 3-26: USA Market for Sutures and Staples, 2010-2017 ($Millions)
Exhibit 3-27: USA Market for Mechanical Closure Devices, 2010-2017 ($Millions)
Exhibit 3-28: USA Market for Tapes, 2010-2017 ($Millions)
Exhibit 3-29: USA Market for Hemostats, 2010-2017 ($Millions)
Exhibit 3-30: USA Market for Fibrin and Other Sealants, 2010-2017 ($Millions)
Exhibit 3-31: USA Market for High-Strength Medical Adhesives, 2010-2017 ($Millions)
Exhibit 3-32: USA Market for Post-Surgical Adhesion Prevention, 2010-2017 ($Millions)
Exhibit 3-33: Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, Rest of North America (Canada and Mexico), 2010-2017 ($Millions)
Exhibit 3-34: Rest of North America (Canada and Mexico) Market for Sutures and Staples, 2010-2017 ($Millions)
Exhibit 3-35: Rest of North America (Canada and Mexico) Market for Mechanical Closure Devices, 2010-2017 ($Millions)
Exhibit 3-36: Rest of North America (Canada and Mexico) Market for Tapes, 2010-2017 ($Millions)
Exhibit 3-37: Rest of North America (Canada and Mexico) Market for Hemostats, 2010-2017 ($Millions)
Exhibit 3-38: Rest of North America (Canada and Mexico) Market for Fibrin and Other Sealants, 2010-2017 ($Millions)
Exhibit 3-39: Rest of North America (Canada and Mexico) Market for High-Strength Medical Adhesives, 2010-2017 ($Millions)
Exhibit 3-40: Rest of North America (Canada and Mexico) Market for Post-Surgical Adhesion Prevention, 2010-2017 ($Millions)
Exhibit 3-41: Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, Latin America, 2010-2017 ($Millions)
Exhibit 3-42: Latin America Market for Sutures and Staples, 2010-2017 ($Millions)
Exhibit 3-43: Latin America Market for Mechanical Closure Devices, 2010-2017 ($Millions)
Exhibit 3-44: Latin America Market for Tapes, 2010-2017 ($Millions)
Exhibit 3-45: Latin America Market for Hemostats, 2010-2017 ($Millions)
Exhibit 3-46: Latin America Market for Fibrin and Other Sealants, 2010-2017 ($Millions)
Exhibit 3-47: Latin America Market for High-Strength Medical Adhesives, 2010-2017 ($Millions)
Exhibit 3-48: Latin America Market for Post-Surgical Adhesion Prevention, 2010-2017 ($Millions)
Exhibit 3-49: Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Devices, European Union, 2010-2017 ($Millions)
Exhibit 3-50: Surgical Sealants, Glues, Wound Closure and Post-Surgical Adhesion Prevention Markets, United Kingdom, 2010-2017 ($Millions)
Exhibit 3-51: United Kingdom Market for Sutures and Staples, 2010-2017 ($Millions)
Exhibit 3-52: United Kingdom Market for Mechanical Closure Devices, 2010-2017 ($Millions)
Exhibit 3-53: United Kingdom Market for Tapes, 2010-2017 ($Millions)
Exhibit 3-54: United Kingdom Market for Hemostats, 2010-2017 ($Millions)
Exhibit 3-55: UK Market for Fibrin and Other Sealants, 2010-2017 ($Millions)
Exhibit 3-56: UK Market for High-Strength Medical Adhesives, 2010-2017 ($Millions)
Exhibit 3-57: UK Market for Post-Surgical Adhesion Prevention, 2010-2017 ($Millions)
MedMarket Diligence Reports are produced through primary
and secondary research. Data is gathered from published sources on products
and technologies on the market and under development. Clinicians and industry
representatives are interviewed for their knowledge and insights on product
development, market development, clinical practice and trends associated with
the evolving use of technologies. Secondary data is used to corroborate and
support assessments and projections. Reports are written and researched
by industry insiders, whose familiarity with the companies, industry dynamics
and other marketplace specifics facilitate the research process and ensure high
quality and thorough reports.
Or contact: Patrick Driscoll, (949) 859-3401 or patrick <at>
mediligence <dot> com.
Refund Policy:
MedMarket Diligence print publications may be returned within 30 calendar days of purchase and must be in re-saleable condition for a refund to be issued. No refunds will be provided for digital products such as PDFs; customers are therefore advised to carefully evaluate information (website samples, descriptions, and information otherwise provided by MedMarket Diligence) on publications prior to purchase.
[Home]
[Reports] [Startups]
[Press Releases] [ONLINE
STORE] [site map]
